XML 47 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Expense The Company recognizes stock-based compensation in the consolidated statements of operations, based on the department to which the related employee reports, as follows:
Year Ended December 31,
202220212020
(in thousands)
Cost of net revenue$734 $620 $577 
Research and development40,635 30,364 22,252 
Selling, general and administrative40,335 28,374 24,172 
Restructuring expense— — 596 
$81,704 $59,358 $47,597 
Summary of Restricted Stock Unit Activity A summary of the Company’s restricted stock unit activity is as follows:
Number of Shares
(in thousands)
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 20215,233 $25.14 
  Granted3,516 49.64 
  Vested(2,183)35.20 
  Canceled(486)33.81 
Outstanding at December 31, 20226,080 $35.01 
Summary of Performance-Based Restricted Stock Unit Activity
A summary of the Company’s performance-based restricted stock unit activity is as follows:
Number of Shares
(in thousands)
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 20212,005 $19.80 
  Granted(1)
654 60.53 
  Vested(701)17.85 
  Canceled(8)40.51 
Outstanding at December 31, 20221,950 $34.07 
________________
(1) Number of shares granted is based on the maximum percentage achievable in the performance-based restricted stock unit award.
Employee Stock Purchase Plan, Valuation Assumptions The fair values of employee stock purchase rights were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:
Year Ended December 31,
202220212020
Weighted-average grant date fair value per share
$11.97 - 14.25
$10.85 - 18.82
$6.41 - 8.66
Risk-free interest rate
1.54 - 4.54%
0.04 - 0.06%
0.12% - 0.15%
Dividend yield— %— %—%
Expected life (in years)0.500.500.50
Volatility
59.78 - 69.74%
43.83 - 61.1%
59.72 - 93.25%
Summary of Stock Option Activity A summary of the Company’s stock options activity is as follows:
Number of Options
(in thousands)
Weighted-Average Exercise PriceWeighted-Average Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2021417 $17.05 
Exercised(24)14.25 
Outstanding at December 31, 2022393 $17.22 2.43$6,564 
Vested and expected to vest at December 31, 2022393 $17.22 2.43$6,564 
Exercisable at December 31, 2022393 $17.22 2.43$6,564